George M Jenkins bought $101k of PVLA
director at PALVELLA THERAPEUTICS, INC.. 4,990 shares at an average of $20.20, traded Apr 9, 2025, filed Apr 10, 2025.
Score components
- +15RoleDirector
- +10Trade size$101k at market
- 0Relative to holdingsHoldings up 2.8%
- +4Price context25% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001583648-25-000025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 9, 2025 | POpen-market purchase Common Stock | +2,500 | $20.13 | $50k | 183,171 | Apr 10, 2025 |
| Apr 9, 2025 | POpen-market purchase Common Stockindirect: by foundation | +2,490 | $20.27 | $50k | 13,516 | Apr 10, 2025 |
Related signals
Other insiders at PALVELLA THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | PALVELLA THERAPEUTICS, INC. | Kathleen Goin Chief Operating Officer | $655k 4,302 shares | -100% | |
| 40Moderate | PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $4.2M 27,500 shares | -15% | |
| 42Moderate | PALVELLA THERAPEUTICS, INC. | Christopher P Kiritsy director | $49k 313 shares | -56% | |
| 22Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | George M Jenkins director | $52k 4,000 shares | +2% | |
| 23Weak | PVLAbuy PALVELLA THERAPEUTICS, INC. | James A Geraghty director | $1 1 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.